CV Sciences (CVSI) Short-term Investments (2016 - 2021)
CV Sciences (CVSI) reported Short-term Investments of $501000.0 for Q2 2021, little changed on a YoY basis from $501000.0 in Q2 2020, and little changed sequentially from $501000.0 in Q1 2021.
CV Sciences (CVSI) Short-term Investments (2016 - 2021) Analysis & Trends
CV Sciences (CVSI) has 6 years of Short-term Investments data on file, last reported at $501000.0 in Q2 2021.
- For the quarter ending Q2 2021, Short-term Investments changed 0.0% year-over-year to $501000.0; the trailing twelve-month figure through Jun 2021 stood at $501000.0 (changed 0.0% YoY), and the FY2020 full-year result was $501000.0, changed 0.0% from the prior year.
- Short-term Investments was little changed at $501000.0 in Q2 2021, from $501000.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $1.1 million in Q1 2017 to a low of $251000.0 in Q4 2018.
- A 5-year average of $626045.7 and a median of $501000.0 in 2019 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments surged 182.49% in 2017 and slumped 67.76% in 2018, its largest moves.
- Tracing CVSI's Short-term Investments over 5 years: stood at $778579.0 in 2017, then sank by 67.76% to $251000.0 in 2018, then surged by 99.6% to $501000.0 in 2019, then changed by 0.0% to $501000.0 in 2020, then changed by 0.0% to $501000.0 in 2021.
- Business Quant data shows CVSI's Short-term Investments at $501000.0 in Q2 2021, $501000.0 in Q1 2021, and $501000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | CV Sciences | 4.11 Mn | 3.80 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 501,000.00 |
| Mar 31, 2021 | 501,000.00 |
| Dec 31, 2020 | 501,000.00 |
| Sep 30, 2020 | 501,000.00 |
| Jun 30, 2020 | 501,000.00 |
| Mar 31, 2020 | 501,000.00 |
| Dec 31, 2019 | 501,000.00 |
| Sep 30, 2019 | 500,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Dec 31, 2018 | 251,000.00 |
| Sep 30, 2018 | 738,356.00 |
| Jun 30, 2018 | 778,579.00 |
| Mar 31, 2018 | 781,310.00 |
| Dec 31, 2017 | 778,579.00 |
| Sep 30, 2017 | 750,185.00 |
| Jun 30, 2017 | 940,653.00 |
| Mar 31, 2017 | 1.12 Mn |
| Dec 31, 2016 | 275,611.00 |